• Levemir^®
  (insulin detemir [rDNA origin] injection)
• NovoLog^®
  (insulin aspart [rDNA origin] injection)
• NovoLog^® Mix 70/30
  (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin])

ABOUT RICK SMOLAN

A former Time, Life and National Geographic photographer, Rick Smolan has spent two decades placing himself and his projects directly in the path of the converging worlds of photography, design, publishing and technology.

Smolan created the best-selling "Day in the Life" photographic series and is CEO of Against All Odds Productions, which specializes in the design and execution of large-scale, global photographic projects that combine compelling storytelling with state-of-the-art technology. Eight of the company's projects have been featured on the covers of Fortune, Time, Newsweek and US News & World Report. Fortune Magazine described Against All Odds as "one of the coolest companies in America."

For his latest project, Rick teamed with Novo Nordisk to produce Meet the Face of Change™, a national photo exhibit currently touring the country. The project documents – and celebrates – the lives of a diverse group of people with type 2 diabetes who are making the changes they need to manage their condition and are not allowing diabetes to get in the way of their passions, hopes and aspirations.

Smolan's other projects include:

AMERICA 24/7, the largest photographic event in United States history. One thousand top photojournalists (including 36 Pulitzer Prize winners) were equipped with digital cameras and sent throughout the U.S. for a week to create an extraordinary snapshot of American life. America 24/7 hit #5 on the New York Times best seller list. The Wall Street Journal featured the America 24/7 project on the front pages of its MarketPlace section because the book represented the first New York Times best-seller that was ever mass-personalized by readers.

America at Home and UK at Home, photographed in September 2007 by 100 of the world's top photojournalists – and millions of amateur shutterbugs – who fanned out around the United States and the United Kingdom to shoot digital photos of the most important place in their lives: Home. America at Home captured the emotions of home: the distinctive rituals, intimate moments and all the myriad ways in which we work, play, learn, conduct our lives and interact with friends and family members (and pets!) as we transform our dwellings into homes. America at Home and UK at Home will be published in Spring 2008 and is being produced in association with IKEA.

The Blue Planet Run: The Race to Provide Clean Drinking Water to the World, released in November 2007. The book provides readers with an extraordinary look at the water problems facing humanity and some of the hopeful solutions being pursued by large and small companies, entrepreneurs and activists and by nongovernmental organizations and foundations. The book is a showcase of powerful, inspiring, disturbing and hopeful images captured by leading photojournalists around the world who documented the human face of the crisis and its possible solutions. One hundred percent of the royalties from the book will be used to provide clean drinking water to the people around the world who desperately need it.

Smolan's next project will be Sixteen in America, a one-week documentation to be shot in the spring of 2008 by 10,000 16-year-olds, using cameras, handicams, tape recorders and Web sites, to capture what its like to be "coming of age" in America at the dawn of the Millennium.

Levemir® [insulin detemir (rDNA origin) injection]

Levemir® is used to treat patients with diabetes for the control of high blood sugar.
It's used once or twice a day to lower blood sugar.

Important Safety Information

Levemir® should not be diluted or mixed with any other insulin or solution.

People who are allergic to insulin or the other ingredients in Levemir® should not take Levemir®.

Insulins, including Levemir®, can cause low blood sugar (hypoglycemia). This is the most common side effect. You must test your blood sugar while using an insulin, such as Levemir®.

If you test your blood sugar and it is too low, you should not take Levemir®. Ask your doctor how often you should test your blood sugar, and what to do if it is high or low. Drinking alcohol may also increase the risk of low blood sugar.

Do not change the insulin you are using without talking to your doctor. Doses of oral antidiabetic medicines may also need to change. Your insulin needs may change due to a number of factors, such as illness, stress, medicines, and changes in diet or exercise routines.

Before starting Levemir®, tell your doctor about all your medical conditions including if you have liver or kidney problems, are pregnant or planning to become pregnant, are breast-feeding or planning to breast-feed, or take any other medicines. Do not start any new medicines until you know how they may affect your insulin dose.

When you take Levemir®, you may notice some side effects common to insulin. These include low or high blood sugar, reaction at the injection site (like redness, swelling, and itching) and allergic reactions. Get medical help right away if you experience signs of serious allergic reaction such as body rash, trouble with your breathing, fast heartbeat or sweating. Ask your doctor or pharmacist for further information.

NovoLog® [insulin aspart (rDNA origin) injection]

NovoLog® is a man-made insulin that is used to control high blood sugar in adults and children with diabetes mellitus.

Important Safety Information

NovoLog® is a fast-acting insulin. You should eat a meal within 5 to 10 minutes after using NovoLog® to avoid low blood sugar. Do not inject NovoLog® if you do not plan to eat right after using NovoLog®. Check your blood sugar levels. Ask your health care provider what your blood sugars should be and when you should check your blood sugar levels. Alcohol, including beer and wine, may affect your blood sugar when you take NovoLog®.

Do not change the type of insulin you use unless told to do so by your health care provider. The amount of insulin you take as well as the best time for you to take your insulin may need to change if you take a different type of insulin.

Do not mix NovoLog® with any other insulins when used in a pump or with any insulins other than NPH when used with injections by syringe.

Do not take NovoLog® if your blood sugar is too low (hypoglycemia) or if you are allergic to anything in NovoLog®. If you take too much NovoLog® your blood sugar may fall too low.

Tell your health care provider about all medicines you take and all of your medical conditions, including if you are pregnant or breastfeeding. Your NovoLog® dose may change if you take other medicines.

The most common side effect of insulin therapy, including NovoLog® is low blood sugar (hypoglycemia). Other possible side effects include reactions at the injection site (like redness, swelling and itching), and allergic reactions. Get medical help right away if you experience signs of serious allergic reaction such as body rash, trouble with your breathing, fast heartbeat, or sweating. Ask your doctor or pharmacist for further information.

NovoLog® Mix 70/30 [70% insulin aspart protamine suspension and 30% insulin aspart injection, (rDNA origin)]

NovoLog® Mix 70/30 is for use in patients with diabetes to control high blood glucose.

Important Safety Information

You should know that NovoLog® Mix 70/30 is different from other insulin mixtures because it works fast. So it's important to take your dose within 15 minutes of a meal. Also, check your blood glucose regularly. Do not use NovoLog® Mix 70/30 if your blood glucose is too low or if you are allergic to this medication. Low blood glucose is the most common side effect. If you have been taking another type of insulin, the time at which low blood glucose could occur may be different. Any change in insulin should be made cautiously and only under medical supervision.

FlexPen®, Levemir®, and NovoLog® are registered trademarks of Novo Nordisk A/S.
© 2008 Novo Nordisk Inc. 135082
Privacy Policy | Contact Us